Pharma, Policy and politics 8/28/13 Pharma, Policy and politics 8/28/13 Oral anticancer law: Unintended consequence Read More Pharma, Policy and politics 7/10/13 Pharma, Policy and politics 7/10/13 Pharmacy Board needs non-pharmacist majority Read More Amusements, International, Pharma, Policy and politics 6/26/13 Amusements, International, Pharma, Policy and politics 6/26/13 Paying their bills: A novel idea in Southern Europe Read More Pharma, Policy and politics, Research 6/13/13 Pharma, Policy and politics, Research 6/13/13 A pain-free way for seniors to chip in on health care costs Read More Pharma 6/12/13 Pharma 6/12/13 Shire finds its home in Massachusetts Read More Pharma, Policy and politics 5/14/13 Pharma, Policy and politics 5/14/13 Are biosimilars ethical? Read More Entrepreneurs, Patients, Pharma 5/1/13 Entrepreneurs, Patients, Pharma 5/1/13 Business opportunity: Safety packaging for home chemo Read More Pharma, Physicians, Policy and politics 4/26/13 Pharma, Physicians, Policy and politics 4/26/13 Oncologists get serious about drug prices Read More Culture, Pharma, Policy and politics 4/25/13 Culture, Pharma, Policy and politics 4/25/13 What to do about heroin and oxycontin Read More Economics, Pharma, Research 4/24/13 Economics, Pharma, Research 4/24/13 $400B in pharmacy waste? Maybe it's higher Read More Pharma 4/21/13 Pharma 4/21/13 Lucentis multi-dosing? Reader comment Read More Entrepreneurs, Health plans, Pharma, Podcast 4/11/13 Entrepreneurs, Health plans, Pharma, Podcast 4/11/13 Castlight president discusses new pharmacy and health plan offerings (transcript) Read More Entrepreneurs, Health plans, Patients, Pharma, Podcast 4/10/13 Entrepreneurs, Health plans, Patients, Pharma, Podcast 4/10/13 Castlight president discusses new pharmacy and health plan offerings Read More International, Pharma, Policy and politics, Research 4/8/13 International, Pharma, Policy and politics, Research 4/8/13 What lessons does the European approach to drug reimbursement have for the US? Read More Pharma, Research 12/10/12 Pharma, Research 12/10/12 JAK2 inhibitor for myelofibrosis: Q&A with Sanofi Read More Pharma, Policy and politics 10/15/12 Pharma, Policy and politics 10/15/12 New England Compounding Center: the Avastin/Lucentis connection Read More Pharma, Policy and politics 10/9/12 Pharma, Policy and politics 10/9/12 Ready for FDA regulation of compounding pharmacies Read More Culture, Patients, Pharma 9/5/12 Culture, Patients, Pharma 9/5/12 Time to talk about constipation Read More Health plans, Pharma, Policy and politics 8/29/12 Health plans, Pharma, Policy and politics 8/29/12 Rerun: Locking out lock-in pricing Read More Economics, Pharma 8/24/12 Economics, Pharma 8/24/12 Rerun: With medication adherence, more is more Read More Newer Posts Older Posts
Pharma, Policy and politics 8/28/13 Pharma, Policy and politics 8/28/13 Oral anticancer law: Unintended consequence Read More
Pharma, Policy and politics 7/10/13 Pharma, Policy and politics 7/10/13 Pharmacy Board needs non-pharmacist majority Read More
Amusements, International, Pharma, Policy and politics 6/26/13 Amusements, International, Pharma, Policy and politics 6/26/13 Paying their bills: A novel idea in Southern Europe Read More
Pharma, Policy and politics, Research 6/13/13 Pharma, Policy and politics, Research 6/13/13 A pain-free way for seniors to chip in on health care costs Read More
Pharma, Policy and politics 5/14/13 Pharma, Policy and politics 5/14/13 Are biosimilars ethical? Read More
Entrepreneurs, Patients, Pharma 5/1/13 Entrepreneurs, Patients, Pharma 5/1/13 Business opportunity: Safety packaging for home chemo Read More
Pharma, Physicians, Policy and politics 4/26/13 Pharma, Physicians, Policy and politics 4/26/13 Oncologists get serious about drug prices Read More
Culture, Pharma, Policy and politics 4/25/13 Culture, Pharma, Policy and politics 4/25/13 What to do about heroin and oxycontin Read More
Economics, Pharma, Research 4/24/13 Economics, Pharma, Research 4/24/13 $400B in pharmacy waste? Maybe it's higher Read More
Entrepreneurs, Health plans, Pharma, Podcast 4/11/13 Entrepreneurs, Health plans, Pharma, Podcast 4/11/13 Castlight president discusses new pharmacy and health plan offerings (transcript) Read More
Entrepreneurs, Health plans, Patients, Pharma, Podcast 4/10/13 Entrepreneurs, Health plans, Patients, Pharma, Podcast 4/10/13 Castlight president discusses new pharmacy and health plan offerings Read More
International, Pharma, Policy and politics, Research 4/8/13 International, Pharma, Policy and politics, Research 4/8/13 What lessons does the European approach to drug reimbursement have for the US? Read More
Pharma, Research 12/10/12 Pharma, Research 12/10/12 JAK2 inhibitor for myelofibrosis: Q&A with Sanofi Read More
Pharma, Policy and politics 10/15/12 Pharma, Policy and politics 10/15/12 New England Compounding Center: the Avastin/Lucentis connection Read More
Pharma, Policy and politics 10/9/12 Pharma, Policy and politics 10/9/12 Ready for FDA regulation of compounding pharmacies Read More
Culture, Patients, Pharma 9/5/12 Culture, Patients, Pharma 9/5/12 Time to talk about constipation Read More
Health plans, Pharma, Policy and politics 8/29/12 Health plans, Pharma, Policy and politics 8/29/12 Rerun: Locking out lock-in pricing Read More
Economics, Pharma 8/24/12 Economics, Pharma 8/24/12 Rerun: With medication adherence, more is more Read More
